Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $239.5700 (-3.39%) ($236.3900 - $249.4300) on Mon. Aug. 20, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.21% (three month average) | RSI | 68 | Latest Price | $239.5700(-3.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.7% a day on average for past five trading days. | Weekly Trend | LGND advances 4.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.105% in a week (0% probabilities). VXX(-16%) TLT(-16%) VIXM(-13%) UUP(-9%) GDXJ(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.105% (StdDev 2.21%) | Hourly BBV | 0 () | Intraday Trend | -3.5% | | | |
|
5 Day Moving Average | $244.74(-2.11%) | 10 Day Moving Average | $243.94(-1.79%) | 20 Day Moving Average | $234.82(2.02%) | To recent high | -3.8% | To recent low | 29.5% | Market Cap | $3.85b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |